Embecta Corp. (EMBC): Operating Income

Annual figures by period end, from SEC filings.

$242.10M
Year ended 2025-09-30
$223.50M
Trailing 12 months to 2026-06-30
-7.9%
3-year compound annual growth
-13.0%
5-year compound annual growth
$492.00M2020-09-30: $486.50M2021-09-30: $492.00M2022-09-30: $309.60M2023-09-30: $221.50M2024-09-30: $166.80M2025-09-30: $242.10M$242.10M
2020-09-30 Operating Income (USD) 2025-09-30
Period endedOperating IncomeChange YoYSource filing
2025-09-30$242.10M+45.1%2025-11-25, From 2024-10-01
2024-09-30$166.80M-24.7%2025-11-25, From 2023-10-01
2023-09-30$221.50M-28.5%2025-11-25, From 2022-10-01
2022-09-30$309.60M-37.1%2024-12-11, From 2021-10-01
2021-09-30$492.00M+1.1%2023-11-29, From 2020-10-01
2020-09-30$486.50Mn/a2022-12-22, From 2019-10-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Embecta Corp. (EMBC)2025-09-30$242.10M+45.1%
Tandem Diabetes Care Inc (TNDM)2025-12-31-$187.26Mn/m
Inspire Medical Systems, Inc. (INSP)2025-12-31$50.95M+41.2%
Haemonetics Corp (HAE)2026-03-28$156.73M-29.3%
Penumbra Inc (PEN)2025-12-31$189.25Mn/m
Orthofix Medical Inc. (OFIX)2025-12-31-$81.43Mn/m
Merit Medical Systems Inc (MMSI)2025-12-31$184.72M+18.6%
Alphatec Holdings, Inc. (ATEC)2025-12-31-$82.13Mn/m
iRhythm Holdings, Inc. (IRTC)2025-12-31-$57.41Mn/m

Compare EMBC, TNDM, INSP, HAE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗